Studies on the antiviral effects of short peptides of six to 10 amino acids that correspond in sequence to the cytoplasmic domains of enveloped virus transmembrane glycoproteins have been extended to include additional kinds of assay in order to determine a site for inhibition of virus replication. Based on these experiments, the antiviral activity previously described for a decapeptide with the influenza virus haemagglutinin HA 2 C-terminal sequence was not specific for influenza virus and the integrity of newly released, extracellular vesicular stomatitis virus particles was affected by the peptide. A shortened, six amino acid form of this peptide inactivated cell-free preparations of influenza, vesicular stomatitis and Sindbis viruses and also bound effectively to virus-encoded structural proteins. For this virus-protein interaction, the peptide sequence was highly specific with respect to its hydrophobicity and net ionic charge.
Summary
Studies on the antiviral effects of short peptides of six to 10 amino acids that correspond in sequence to the cytoplasmic domains of enveloped virus transmembrane glycoproteins have been extended to include additional kinds of assay in order to determine a site for inhibition of virus replication. Based on these experiments, the antiviral activity previously described for a decapeptide with the influenza virus haemagglutinin HA 2 C-terminal sequence was not specific for influenza virus and the integrity of newly released, extracellular vesicular stomatitis virus particles was affected by the peptide. A shortened, six amino acid form of this peptide inactivated cell-free preparations of influenza, vesicular stomatitis and Sindbis viruses and also bound effectively to virus-encoded structural proteins. For this virus-protein interaction, the peptide sequence was highly specific with respect to its hydrophobicity and net ionic charge.
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Considerable attention has been directed in recent years to the potential role of short peptides as antiviral agents (Andrei et al., 1994; Cohen et al., 1986; Digard et al., 1995; Divita et al., 1994; Dutia et al., 1986; Lambert et al., 1996; Liuzzi et al., 1994; Nasser et al., 1996; Schramm et al., 1996; Wild et al., 1992) . Some studies were based on the rationale that interactions among virus-encoded proteins are unique to the virus and distinct from most cellular proteins. Our studies with a small hexapeptide that specifically interfered with a late step in Sindbis virus replication (Collier et al., 1992) and similar results with Semliki Forest virus (Kail et al., 1991) suggested that a peptide whose sequence corresponded to a short region of the cytoplasmic domain of one of the virus transmembrane glycoproteins could block interactions between this domain and complementary sites on the surface of the virus nucleocapsid. Recent analysis of the structure of the latter, based on a combination ofX-ray diffraction data, molecular modelling and reconstructions derived from cryo-electron microscopy are consistent with the interpretation of the peptide's antiviral activity (Lee et al., 1996; Skoging et al, 1996) . Comparable studies with the WSN strain of influenza A virus adapted to grow in tissue culture showed that a 10 amino acid peptide corresponding in sequence to the entire cytoplasmic domain of the virus haemagglutinin HA 2 could inhibit virus particle release with a 50% inhibitory dose at levels of approximately 50 /-Lg mL-l or 40 11M (Collier et al., 1991) . To measure inhibition of virus particle formation, virus-infected chicken embryo fibroblast (CEF) cells were treated with peptide for 2 h commencing at 4 h post-infection and labelled with [35S]methionine during this time period. Virus-specific proteins that accumulated in the infected cells and that were released into the culture medium were quantitatively evaluated. These analyses showed that the decapeptide had little or no effect on intracellular virus protein synthesis but there were decreased amounts of cell-free virus proteins; we postulated that the peptide was acting during virus assembly and budding; Further studies confirmed that this peptide also inhibited the formation of infectious virus secreted into the media of infected tissue culture cells (Gorka etal., 1994) . Titres of virus, based on plaque formation, were measured in media from infected cells harvested over a similar 2 h period shortly after infection. Shorter versions of the peptide inhibited infectious virus yields, but a hexapeptide with a sequence corresponding to the C terminus of influenza virus HA 2 also inactivated Sindbis virus in this assay. Here, we report results with these peptides based on additional types of assays for measuring newly replicated intra-and extracellular virus. They indicate that the peptides inhibited virus primarily by inactivating newly formed particles released from the cell. In addition, the response appears not to be as highly specific with regard to virus as originally surmised.
One of these assays measured virus particle formation by subjecting the cell-free medium to isopycnic centrifugation in a sucrose gradient. At levels of100 Ilg mL-l (80 IlM) of the peptide NGSLQCRICI-NH 2 , which corresponds to the cytoplasmic domain sequence of thef rom the H1N1 group of influenza A viruses, intact influenza virus particle formation ( Fig. La) was totally blocked, a result consistent with our earlier studies. By this CEF cells infected with influenza virus strain A/WSN/33 (a) or VSV strain San Juan (b) were analysed by isopycnic centrifugation in sucrose gradients. For isopycnic centrifugation, we used procedures previously described (Loewy et al., 1995) . The density of the peak of radioactivity (fraction 8) was 1.18 g cm-3 and corresponds to the bouyant densities of influenza virus (1.18 g cm-3 ) and rhabdoviruses (1.17-1.19 g cm-3 ). hexapeptide that contained all D-amino acid residues were not inhibitory (Gorka et al., 1994) . From the results cited above, it appeared that the peptides were inactivating newly released virus particles rather than interfering with intracellular assembly and budding events. This hypothesis was supported further when we compared the effect of the hexapeptide GCRICI-NH 2 on the growth of influenza virus in CEF cells. In the presence of peptide (250 J.lM), titres of cell-free virus decreased by >95%. However, 60 to 90% of the total infectious influenza virus made in these cells remained strongly bound to the cell, as determined by comparing titres of the media and washed cell monolayers with the titres ofvirus present in a hypotonic lysate of the cells (Table 1) . For this latter, larger a Peptide synthesis is described in our earlier publications (Collier et a/., 1992; Ryan et 0/., 1995) . Peptides were purified by HPlC; their purity assessed by ion-spray mass spectroscopy and stored lyophilized at -20°C. Samples (1 to 10 mg ml-1 ) were diluted in PBSsolution to 0.2 mg ml-1 and 90 III adsorbed for 12 h to a 96-well Nunc dish. After three washes with PBS and a 2 h incubation at 23°C with PBS, the wells were washed thoroughly with PBS. Then, [35S1methionine-labelled samples (45 Ill) of virus or virus-infected cell extracts that had been solubilized in RIPA buffer (50 mM Tris-HCI pH 7.2, 150 mM NaCI, 1% deoxycholate, 1% Triton X-I 00 and 0.1 % SDS) were added for 1 h. Radioactive labelling of infected cells has been described (Collier et a/., 1991) and radioactive and unlabelled virus was prepared by isopycnic centrifugation of cell-free media. After wells were washed three times with PBSfollowed by 35 J-ll of 1% SDS, a 5 III sample was analysed for radioactivity using Beckman Redi-caps. b The data hove been normalized to binding of the hexapeptide with sequence (shown in the first line) identical to the C terminus of the influenza virus HA z. The value of 1 represents 20% of the total input radioactivity. An uninfected cell extract gave values between 1 and 2%. As a control peptide, the Sigma product acetyl-FnlRF-NH z was bound to wells; it failed to bind any radioactive material. C Peptide with OH (free acid) was <0.1. d All D-amino acids. assay, however, the peptide also affected the banding of most of the vesicular stomatitis virus (VSV) particles (Fig.  Ib) . An SDS-PAGE analysis of VSV particles, which were produced in the presence of the decapeptide and isolated by ultracentrifugation of cell-free media in the absence of sucrose, showed that these particles contained aberrant forms of the VSV G protein, in contrast to the proftle of intracellular G protein, which was indistinguishable from that formed in the absence of the peptide (data not shown). These data indicated that the peptide was altering extracellular VSV virus structure rather than interfering with virus assembly. An assay of proteins by SDS-PAGE of cell-free influenza virus particles formed in the presence of the peptide showed decreased levels of the major virus proteins but no major qualitative changes (Collier et al., 1991) .
To test for a more direct interaction between peptide and virus we measured changes in titres of cell-free virus that had been incubated with the peptide for periods of up to 2 h and then frozen prior to dilution and plaquing. The decapeptide at levels o£160 J.lMreduced titres of influenza by 90 to 95% and titres of VSV by 2 10glO' Titres of Sindbis virus were reduced by about 30%. Titres of VSV samples treated with peptide but not subsequently frozen were also reduced by 2 10glQ; however, titres of influenza virus treated with peptide but not frozen decreased by 50% and titres of Sindbis virus were not affected if the freezing step was omitted. The reduction in titres of virus that had been previously frozen and then thawed and incubated with peptide were not significantly different from those of unfrozen samples incubated with peptide. Apparently, freezing of virus in the presence of peptide significantly enhanced the effect of the latter on virus integrity.
Based on the assay for virus particle integrity by banding in an isopycnic gradient, a shortening of the peptide from its N terminus to the octapeptide SLQCRICI-NH 2 retained antiviral activity (>90% inhibition) for influenza virus at a level of 100 J.lM (data not shown). The heptapeptide LQCRICI-NH 2 and hexapeptide QCRICI-NH 2 were less effective inhibitors by this assay at similar concentrations. The hexapeptide had little effect on banding ofVSV or Sindbis virus particles in isopycnic centrifugation in sucrose (data not shown). In the assay for virus infectivity, which was performed on samples that had experienced a freeze-thaw in the presence of the hexapeptide, titres of influenza virus were reduced by 90 to 95%, VSV by >95% and Sindbis virus by 90%.
Some modifications of the shorter peptides rendered them inactive when tested with influenza virus by the infectious titre assay. The pentapeptide QRICI-NH 2 , lacking cysteine at position 2 of the active hexapeptide (numbering is from the N terminus), was inactive in the plaque titre assay (data not shown). From earlier studies, a heptapeptide lacking the isoleucine at position 5 and a Peptide sequence Chemotherapy 8(4) fraction of newly replicated, cell-associated virus, the hexapeptide inhibition was only about 35%. Similar results were obtained for VSV; the hexapeptide inactivated cellfree virus by 1.4-to 3-fold more than that measured for cell-bound virus (Table 1) .
Further support for a direct interaction between peptide and virus emerged when we established a peptide-binding assay in which the influenza HA 2 hexapeptide was fixed onto microtitre wells and radioactive virus proteins were tested for their ability to bind to these wells. Under appropriate conditions, we found that significant amounts of influenza virus proteins extracted from infected cells could bind to these peptide-coated wells. However, in a manner similar to that noted above, this binding was not specific for influenza virus. There was, however, considerable selectivity with regard to binding of a specific virus protein.
For influenza virus, the matrix (M) protein bound better than the other virus proteins; for VSv, the nucleoprotein (NP) bound better; for Sindbis virus, the E1 protein was selectively bound. Thus, this hexapeptide peptide was promiscuous for its target, but what proved intriguing in these studies was the observation that the sequence of the peptide was critical for effective binding.
In the assay, binding was saturable both with regard to the amount ofpeptide fixed onto the well (around 0.2 nM) and the amount of labelled protein. A 1 h incubation period was optimum. Binding was performed at 4°C but temperature (4°C versus 23°C) had relatively little effect on the kinetics of binding. Reversal of binding was detected when a non-labelled virus sample was added 1 h after the labelled sample had been bound. To determine which amino acids in the peptide were critical for binding, modifications were made in the sequence of the hexamer, QCRICI-NH 2 ( Table 2 ). The data showed that (i) a positively charged amino acid is essential and that its position relative to the hydrophobic groups is also important; (ii) hydrophobicity is essential since substitution of valine for isoleucine blocks binding and a free carboxyl also interferes; (ii) at least one cysteine is needed and this must be at a particular position in the peptide. Pretreatment of the peptide with dithiothreitol had Iittle effect, indicating that the disulphide configuration of the cysteines was not essential. A search of the protein database for proteins with sequences closely resembling the consensus sequence of the hexapeptide tested here showed very few proteins, other than the influenza virus haemagglutinins, that fitted the requirements noted above. Based on the numbers of sequences examined (104262), the number ofpositive hits was that expected from a random array of these six amino acids. The first four of the hexapeptides in Table 2 were roughly equivalent in reducing titres ofVSVby >95% at 80 levels. The others were not tested in this assay. The data presented here indicate that the HA 2 hexapeptide is binding through hydrophobic interactions to 314 external structures of virus newly released from infected cells, thereby leading to its inactivation and denaturation, rather than via a mechanism related to intracellular assembly. A similar fInding was made in studies with respiratory syncytial virus and a peptide with sequence resembling the cytoplasmic domain of the G glycoprotein of this virus (Ryan et al., 1995) .
The binding assay described here helps somewhat to explain a mechanism for peptide-mediated inactivation of virus proteins. An ionic interaction may be involved in an initial binding of peptide to protein but the peptide's hydrophobicity suggests that it is inserted into the protein's tertiary structure, perhaps leading to localized unfolding. It is noteworthy that the virus proteins that were most dominant in binding, the M of influenza virus, NP ofVSV and E1 of Sindbis virus all bind to cellular membranes. The thiol groups might act to rearrange disulphides in the target protein. Attempts to rearrange the amino acids Were unsuccessful and it remains an intriguing puzzle why this particular peptide functions in the manner shown. Perhaps additional modifications could lead to greater inhibitory activity and its use as an antiviral agent.
